HHS funds vaccine candidates for Marburg, Sudan ebolavirus
The Department of Health and Human Services yesterday awarded $20.5 million to develop vaccine candidates for Marburg virus and Sudan ebolavirus, which are in the same family of viruses as the Ebola virus outbreak in the Democratic Republic of the Congo. The last outbreaks of Marburg virus and Sudan ebolavirus were in Uganda, in 2017 and 2012, respectively. The Sabin Vaccine Institute will conduct nonclinical studies and complete manufacturing activities to advance the development of the vaccine candidates under a contract with HHS’s Biomedical Advanced Research and Development Authority. BARDA also is helping to develop and procure vaccines, therapeutics and diagnostics for the Ebola strain circulating in the Congo.
Related News Articles
Headline
A study published Dec. 3 by the New England Journal of Medicine found that one dose of the HPV vaccine could be as effective as two in preventing cervical…
Headline
The Centers for Medicare & Medicaid Services Innovation Center will launch a new, outcome-aligned payment model for providers offering technology-supported…
Headline
The House Ways and Means Subcommittee on Health held a hearing Nov. 19 to discuss improvements to care coordination and delivery to prevent and treat chronic…
Headline
Elizabeth Dabrowski, M.D., pediatric endocrinologist at Children’s Wisconsin, and Matthew Edwards, R.D., diabetes care and education specialist at Children’s…
Headline
The American Heart Association released a study Oct. 28 that found disruptions to people’s circadian rhythm can increase their risk of cardiovascular disease…
Headline
There have been 1,596 confirmed cases of measles across the U.S. this year, according to the latest data from the Centers for Disease Control and Prevention.…